Meet the Arangio family, our dedicated community champions who are spearheading an extraordinary event, the Blue Ribbon Gala, in support of Diabetes Canada. Motivated by a personal journey that hit close to home, the Arangio family has chosen to channel their experiences into raising awareness about diabetes and its impact on families. This inspiring initiative was born out of unforeseen circumstances when diabetes unexpectedly touched their lives in a profound way. Determined to make a difference, the Arangio family has transformed their personal connection with diabetes into a beacon of hope and advocacy.
Diabetes Canada is proud to be a leading supporter of diabetes research in Canada. Since 1975, we’ve supported outstanding diabetes research in Canada and provided more than $160 million in research grants, awards and partnerships to scientists across the country.
Since the discovery of insulin in Toronto in 1921, Canadian researchers have made huge strides and key advances in understanding diabetes. This is why, each year, we choose to fund Canada’s most renowned researchers in their quest for new and innovative developments in the prevention, treatment, management and cure for diabetes. The research is diverse in scope, covering a broad range of specialties and topics, and the underlying goal of each study remains the same—to create a world free of the effects of diabetes.
Cocktail hour: 5:30 p.m.
Dinner: 6:30 p.m.
How many people have diabetes in Canada?
- 11 million Canadians are living with diabetes or prediabetes.
- Today, one in three Canadians lives with prediabetes or diabetes. Canadians at age 20 face a 50 per cent chance of developing diabetes in their lifetime.
- According to Stats Canada, not including accidents, diabetes is the fifth leading cause of death for all ages in Canada.
- Twenty people are diagnosed every hour of every day.
Research Areas
Diabetes Canada funds research covering an array of topics to ensure that we are funding the best in biomedical, clinical, health services, and/or population health research to improve the lives of people living with or at risk of diabetes and its complications.Research can be broken down into four big categories. The Canadian Institutes of Health Research (CIHR) defines these categories as “pillars”. Each pillar interacts with the others to create a pipeline of research that goes from labs and test tubes to medications and treatments that can be used by people living with diabetes.
Pillar 1: Biomedical research
Involves studying molecules, cells and tissues to find out, at the microscopic level, how our bodies work in health and disease. Takes about 10 to 40 years before it impacts people with diabetes.Pillar 2: Clinical research
Involves studying people, taking that information and turning it into treatments, diagnostic tests and cures. Takes five to 15 years before it impacts people with diabetes.Pillar 3: Health services research
Involves measuring how treatments are being delivered to the population and whether they provide the promised benefit. Takes one to five years before delivering results that can be used to develop policy. How and when it impacts people with diabetes depends on governments implementing the findings.Pillar 4: Population & public health
Involves studying the health of whole populations and subgroups within those populations, in particular, finding out if everyone is benefiting equally from advances in health services. Takes one to five years before delivering results that can be used to develop policy, and also depends on government action.To purchase tickets, contact Connie Arangio, arangiohealthfoundation@gmail.com